In an arterial graft transplantation model that induced atherosclerosis, the administration of neutralizing antibodies against CCL21 and CXCR3 suppressed TLS formation and prevented the progression of atherosclerosis [127]. This evidence concerns the gene CCL21 and atherosclerosis.